ORF Genetics is a privately-owned Icelandic company founded in 2001. The company has established itself as a global leader in barley biotechnology, with a strong focus on developing innovative solutions for protein production. The company's unique expression system, Orfeus™, utilizes barley grain to produce recombinant proteins more efficiently and safely than traditional methods. ORF Genetics has successfully developed a diverse portfolio of growth factors for various markets including stem cell research, skincare, and cultivated meat. One of the company's notable ventures is ISOKINE™, which offers endotoxin-free growth factors and cytokines at lower list prices compared to market leaders, without compromising on bioactivity. Additionally, the development of BIOEFFECT™, a plant-based anti-aging skincare range, has gained significant traction, being used by over 30% of Icelandic women since its launch in 2010 and being retailed in premium stores such as Harrods and Bergdorf Goodman. The company's latest project, MESOKINE™, presents an innovative solution for the FoodTech industry by producing growth factors for cultivated meat, addressing the environmental and ethical challenges associated with the global meat industry. Notably, ORF Genetics operates in an eco-friendly greenhouse located in an Icelandic lava field, emphasizing its commitment to sustainable practices. In March 2013, the company received a ISK12.50M grant investment from the Technology Development Fund, signaling external validation and support for its pioneering work in biotechnology. ORF Genetics continues to drive innovation in protein production and expand its market impact across diverse industries.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Grant | ISK12.50M | 1 | 01 Mar 2013 | |
Grant | ISK12.50M | 1 | 01 Mar 2012 | |
Grant | ISK12.50M | 1 | 01 Mar 2011 | |
Grant | ISK75.00M | 1 | 01 Mar 2010 | |
Grant | ISK3.00M | 1 | 01 Mar 2009 |